Format

Send to

Choose Destination
Heart Fail Clin. 2013 Jul;9(3):321-30, vi. doi: 10.1016/j.hfc.2013.04.006. Epub 2013 Jun 5.

Optimal utilization and management of implanted cardiac rhythm devices in patients hospitalized for heart failure.

Author information

1
Division of Cardiology, Duke University Medical Center, 2301 Erwin Road, Durham, NC 27710, USA. tiffany.callaway@duke.edu

Abstract

Improved utilization and optimization of device therapy in the management of patients with decompensated heart failure (HF) is an important clinical priority. Diagnostic cardiac rhythm device data have been shown to predict hospitalization for HF. Cardiac resynchronization therapy is a highly effective therapy for the prevention of HF hospitalization. Evaluation and optimization of cardiac resynchronization therapy should be considered in all patients admitted with HF despite cardiac resynchronization therapy.

PMID:
23809418
DOI:
10.1016/j.hfc.2013.04.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center